Ono Pharma's Wild 2016 Ride Cuts Stock Valuation by $16 Billion

Ono Pharma's Wild 2016 Ride Cuts Stock Valuation by $16 Billion


Having surged as much as 34 percent as of mid-April, the stock finished the year down more than 41 percent, marking its worst performance in more than 50 years. The swing reduced its market capitalization by about 1.87 trillion yen from a record high in April.



from Biotech News